To assess the reliability and target positioning reproducibility with eyes closed in uveal melanoma patients treated with a micromultileaf-based linear accelerator dedicated for stereotactic radiotherapy. Five consecutive patients treated with curative radiotherapy for uveal melanoma were monitored for positioning reproducibility with resimulation CT scans performed every two days while on treatment (23 resimulation CTs available). All patients underwent MRIs of the orbits before simulation to help to define the target and organs at risk (e.g., lenses, optic nerves, ciliary bodies, and lacrimal glands) in the simulation CT (MRI-to-CT bone registration). Patients were simulated, resimulated, and treated with eyes closed. Patient #1 was treated with 5 daily fractions while patients #2 to #5, were treated with 10 daily fractions. We chose the lens of the tumor-bearing eye as the structure to be controlled, assuming that correct repositioning of the lens should be a valid surrogate for correctness of target repositioning. Displacements (mean and standard deviations, SD) of the lens in the three axes were measured for each patient. Systematic and standard errors were calculated. Planning target volume (PTV) margins were estimated according to McKenzie et al. [Phys Med Biol 45, 3331-3342 (2000)].
Introduction
Uveal melanoma (UM), with an incidence of 6-8 cases/million/year, is the most frequent intraocular tumor in adults (1). Standard treatment of non-metastatic tumors consists either of enucleation of the ocular globe or radical radiotherapy (RT). Brachytherapy with radioactive episcleral plaques (e.g., ruthenium, iodine, paladium, iridium, or cobalt) or external beam RT with charged particles (proton or helium ion beams) are both widely accepted as equally effective treatment alternatives to eye enucleation (2-6). In addition, there is growing interest in photon radiosurgery or fractionated stereotactic radiotherapy (FSRT) as alternatives to the more established treatment options. In these newer techniques pa-Technology in Cancer Research & Treatment, Volume 6, Number 5, October 2007 tients have been treated using either adapted linear accelerators (linac) or gamma-knife units. Single fraction treatments have been associated with an unacceptably high incidence of late effects, especially in large tumors (7, 8) . In contrast, preliminary data have demonstrated the feasibility of FSRT and suggest that tolerance and tumor control appear acceptable; at least for small and moderate sized tumors (9, 10) .
Ocular immobilization in patients treated with proton beams and linac-based FSRT is usually undertaken with the active participation of patients, who are instructed to fix their gaze on a fixed luminous spot. The position of the treated eye is monitored with a video-camera during each treatment session (5, 6) . This immobilization procedure may be unreliable both for patients with impaired vision and in the case of long treatment sessions with a large number of beams, as is frequently the case for FSRT.
Spontaneous blinking and fatigue may both be limiting factors for immobilization methods relying on gaze fixation. Blinking may cause a 1-2 mm shift of the ocular globe inside the orbit with a simultaneous brief rotation of the eye by 1-5º along the cranio-caudal axis towards the nose (11). This rotation seems unavoidable even with the eyelids retracted mechanically. In addition, during steady fixation gaze may be disrupted by unwanted eye movements more prominent in the torsional plane (12). The slow drifts that occur during attempted fixation are small (SD of position <0.1º). Nevertheless, when moving the eyes away from the central to an excentric position in the orbit, stability of gaze becomes a problem because of elastic-restoring forces that may cause gaze-evoked nystagmus (12).
Radiosurgery of choroidal melanomas has also been attempted with retrobulbar anaesthesia for eyeball immobilization. Although, 3-year local control rate as high as 98% with an acceptable tolerance has been reported by a German group with such invasive immobilization system (13), the need for repeated retrobulbar anaesthetic infiltrations in a FSRT setting may carry an unacceptable risk of complications. Indeed, according to several reports, there is a non-negligible risk of severe morbidity with retrobulbar anaesthesia (14, 15) . The risk may be further increased by repeating that invasive immobilization procedure during a multi-fractionated treatment interval.
Closing the eyes causes a slow and tonic rotation of the ocular globe either up or down around the right-to-left axis. This movement differs among individuals but is constant for each individual patient (16). Furthermore, when covering the eye, the slow movement towards its neutral position takes 5-10 seconds to be reached (17). These observations are the rationale for our proposition to treat UM patients with FSRT with eyes closed. Hence, the goal of the present study was to demonstrate that this simple eye repositioning method is feasible and reproducible.
Methods and Materials
Since 2003, patients with localized UM are treated with radical FSRT at Instituto Oncológico Teknon using a specially-designed 6 MV linac equipped with a micromultileaf collimator (Novalis ® , BrainLAB AG). The first five patients treated with this technique were all monitored for positioning reproducibility and are the object of this study. There were four females and one male with ages ranging from 32-56 years and large tumors in every case (i.e., either diameter >15 mm, or height >5 mm). Tumors were located anterior to the equator in two patients and posterior to the equator in three patients (all three cases extending towards the optic disk).
Before treatment planning, patients were immobilized with a customized thermoplastic mask especially designed for stereotactic RT of brain lesions. To optimize head fixation, a nose bridge mold and a bite block were also used. With the patients in the treatment position and the head-mask set up into a especially designed stereotactic frame, planning CT scans were performed with 3 mm slice spacing and 3 mm slice thickness, including the top of the head and the orbits. The in-plane resolution (pixel size) was variable from CT study to CT study but always in the range of 0.53 mm to 0.94 mm. The CT acquisition time was of 30 to 40 seconds. The image plane orientation was 0º (in relation to the axis of the couch motion). No contrast was used. Patients were asked to gently close their eyes and keep them closed during the CT exam. For anteriorly located tumors the involved eye, while closed, was covered with bolus material.
A pre-planning MRI of the top of the head including both orbits (2 mm slice increments) was performed for each patient without the stereotactic frame and mask but with eyes closed. The optimal definition of the tumor and the critical ocular substructures on MRI images helped to precisely delineate the target and the organs at risk (e.g., lenses, optic nerves, ciliary bodies, and lacrimal glands). Tumor and normal structures were first drawn in each axial MRI slice as viewed in the treatment planning system (TPS). After image acquisition, CT and MRI skull-based registrations were performed on the TPS. The tumor (clinical tumor volume, CTV) was defined as the contrast medium-enhanced tumor visible on the MRI (axial reconstruction). The CTV and organs at risk as drawn on MRI were registered on the planning CT and used for final treatment planning and dosimetric purposes. The planning target volume (PTV) was defined as the CTV plus 2 to 3 mm expansion in all directions. After several treatment planning attempts a treatment delivery technique was chosen that employed five (three patients) or six (two patients) non-coplanar intensity modulated beams ( Figure 1 ). Each treatment field was delivered in 10 to 15 seconds with the maximum dose rate available (800 MU/ min) for a continuous eye closure time of 10 minutes. Patient #1 was treated in 5 daily fractions (i.e., 5 × 10 Gy) over one week while patients #2 to #5, were treated in 10 daily fractions (i.e., 10 × 5 Gy) over two weeks.
Resimulation CT scans were performed every two days while on treatment (23 resimulation CTs available). We chose the lens of the ipsilateral tumor-bearing eye as the structure to be controlled for repositioning. It was considered that a correct repositiong of the lens might be a valid surrogate for target repositioning correctness. Displacements (mean and standard deviations, SD) of the manually contoured lens center in the three axes were measured for each patient. Systematic and standard errors were calculated. PTV margins needed to treat patients with eyes shut were estimated according to McKenzie et al. (18) as follows:
In which "Σ" is the SD of the individual displacements of the manually contoured lens center; "σ" is the random error (takes in account organ motion and penumbra) and "σ p " is the SD describing the width of the beam penumbra (3.2 mm); "β" is a penumbra correction coefficient that depends on the number of beams used to treat a spherical volume in order to deliver at least a 95% of the dose to the CTV (0.52 for the transverse plane, and 1.64 in the cranio-caudal direction for a 6 field arrangement). Figure 2 shows the lenses defined on each control CT scan and the respective lenses defined on the planning CT for every patient in the study after CT-to-CT skull registration. Table  I shows the manually contoured lens center shifts (mean and SD) in the three axes across sequential control CT-scans. For both AP-PA and left-right shifts calculated SD were always below 1 mm, except for patient #4 who was treated with a non-customized bolus that pushed the globe backwards in a random fashion compared to the planning CT (Fig. 2) . PTV margins around the target volume, in ideal set-up conditions, were estimated to be 3 mm. Table II summarizes the results and outcome after FSRT for the five patients in our study. Indeed, all patients responded to treatment, though, two with a minor response. Three patients retained the eye and no patient presented with a disease progression after a 3 to 4 year post-treatment follow-up period.
Results

Discussion
Effective immobilization, precise target volume definition, and reliable safety margins around the target are key elements of an optimal treatment of UM patients using external RT techniques, either with charged particles or FSRT (6, 10, 19) . The large and successful >25 year experience with proton beams both at the Harvard Cyclotron Laboratory (HCL) and at the Paul Scherrer Institute (PSI) in Switzerland (more than 7000 patients treated so far) is based upon gaze fixation on a luminous spot for eye immobilization (with retracted eyelids to avoid blinking), an invasive method of target definition (tantalum rings), and defining safety margins of 2 mm around the target (6, 19) . Recently, a group from Vienna has reported on a gaze fixation method using a microcamera integrated in the customized thermoplastic immobilization mask to monitor eye immobilization (20) . In this approach the healthy untreated eye is used for gaze fixation, but eyelid retractors to avoid blinking during treatment are not employed. However, gaze fixation is inconvenient for FSRT techniques using a large number of beams (resulting in long treatment sessions) when compared with proton beam techniques employing a single beam (allowing a very short dose delivery time). Nevertheless, completely blind patients (unable for gaze fixation) treated at PSI with proton beams for ocular melanoma are usually requested to keep their eyes closed during treatment (Egger, E., oral communication) .
In contrast to the invasive tantalum ring localization method used both at HCL and PSI for treating patients with proton beams, it is now possible to rely on non-invasive tools for precise definition of the treatment target, thanks to recent progress in ocular imaging, especially ultrasound, magnetic resonance, computerized tomography, and image registration. In addition, powerful CT-based treatment planning systems (TPS) are currently available for elaborating treatment plans and for optimizing beam arrangements and 3-D dosimetry in a relatively short time frame. The use of multiple non-coplanar beams, not only for FSRT but also for proton beam delivery techniques, may reduce the dose received by the anterior segment of the eye when compared to the classical single-beam treatment method projected through the anterior pole of the ocular globe. The latter approach delivers full dose to non-target substructures in the anterior chamber, such as the ciliary bodies and the lens, increasing the risk of neovascular glaucoma and the need for enucleation (21, 22) .
Several pitfalls were observed with preplanning MRIs for target definition. Indeed, MRI-to-CT planning registration was suboptimal for both patients treated with bolus in this series (patients #4 and #5). In both cases MRI would have been more advantageous for precise target definition if performed in exactly the same immobilization conditions (mask and bolus) as the planning CT. Furthermore, the use of a non-customized bolus for patient #4 was probably the reason for a random and unpredictable shift of the involved ocular globe in the AP-PA axis due to random differences in daily setup of the bolus over the eye (i.e., largest SD in this series, 1.4 mm). This was corrected for patient #5, for whom a customized wax bolus was incorporated into the immobilization mask from the very beginning. Thus, a much smaller shift in the AP-PA axis was observed (i.e., 0.6 mm, SD) compared to patient #4.
An additional problem for monitoring repositioning probably resulted from the rather large 3 mm CT slice increments used in this study, perhaps explaining the larger uncertainties observed in the cranio-caudal axis compared to the two remaining spatial coordinates (see Table I ). We assume that a smaller slice increment (e.g., 2 mm) may help to reduce such uncertainties and confirm the good quality in eye repositioning with eyes shut in future cases. Although standard, the 3 mm slice thickness limited a correct assessment of the precision accuracy in repositioning because of a reduced spatial sampling resolution (i.e., 1.5 mm) larger than the SD of the lens shifts in all five patients in the study.
Table I
Repositioning control with eyes closed: shifts of the manually contoured lens center (in mm) -mean (SD) -in sequential control CT scans.
Right-Left
Antero Furthermore, although the present study suggests a satisfactory inter-fractional positioning reproducibility of the ocular globes with eyes closed it can not be completely ascertained that no intra-fractional shifts of the lenses happened during the 10 minutes treatment time with the eyes closed. With a CT acquisition time of 30-40 seconds in our study, one might consider that an optimal documentation of the reliability of lens repositioning might be ideally obtained by repeating the CT acquisition at least once more during the treatment interval. This was, unfortunately, not done in our study and is an additional pitfall we have to admit. However, gaze fixation for long treatment times without blinking, an immobilization alternative as mentioned above, may not be reliable enough and, therefore, be an handicap for ocular melanoma FSRT.
We chose to monitor the lens of the tumor bearing eye in order to estimate the safety PTV margins. Assuming that the eye ball is spherical any deviation of the lens may correspond to a similar motion and rotation of the target. Indeed, the lens is a structure that may be more easily defined than the target in sequential CT images; therefore, better suited for ocular motion-rotation and for target spatial repositiong reproducibility assessment
As mentioned above, it is widely accepted that safety margins of 2-3 mm around the clinical target volume should be routinely planned for treating UM with proton beams and FSRT (6, 10). Egger et al. (6) , reporting on 2,435 patients treated at PSI with proton beams, observed a highly significant 10-fold increase in local failures (26.5% versus 2.7%) when safety margins at the distal end of the tumor were reduced from 2 mm to <1 mm. Others, however, have not observed such a correlation between safety margin size and local failure (23). Thus, although the safety margin issue remains controversial, the risk of target underdosage remains a key question that may translate into suboptimal treatment control. Furthermore, dosimetric calculations with proton beams both at HCL and PSI rely on water-equivalent calculations (a density of 1.05 g/mm 3 is used in the OPTIS-PSI treatment program) rather than CT-based electron density data, as is the case using commercially based TPS for FSRT (as in the present study). It remains unclear how electron density data may influence treatment accuracy and recommendations on safety margins around the target. In our study, though, all patients responded with no progression and taking in account that all tumors were extra-large, with ocular enucleation as the only alternative, we were able to preserve the eyeball in three out of five patients with a follow-up of 3-4 years after SRT.
In summary, asking patients to close their eyes may be a simple and reliable immobilization procedure when treating ocular tumors with stereotactic radiotherapy. Margins of 3 mm around the target may be necessary to safely treat these tumors under ideal set-up conditions.
